Literature DB >> 17673882

Use of endovascular stents in atherosclerotic renovascular stenosis: blood pressure and renal function changes in hypertensive patients.

Rodrigo Tagle1, Monica Acevedo, Meng Xu, Marc Pohl, Donald Vidt.   

Abstract

Atherosclerotic renal artery stenosis may result in hypertension and ischemic nephropathy. Renal artery endovascular stenting has emerged as current therapy; however, the percentage of patients who benefit from this procedure is still not well established. The authors studied 116 hypertensive patients with atherosclerotic renovascular stenosis who underwent successful renal artery stenting for the first time. At 1 year, there was a significant overall decrease in blood pressure in the group after stenting; however, there was no change in renal function. Also, no significant change in the number of antihypertensive drugs was noted. Blood pressure improved in 55% of the patients, worsened in 14%, and remained unchanged in 31%. Renal function improved in 16% of the patients, worsened in 30%, and remained stable in 54%. In relation to blood pressure control, patients with resistant or difficult-to-control hypertension showed the most improvement in blood pressure control after stenting.

Entities:  

Mesh:

Year:  2007        PMID: 17673882      PMCID: PMC8110130          DOI: 10.1111/j.1524-6175.2007.07100.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  20 in total

Review 1.  Atherosclerotic renal artery stenosis: to treat conservatively, to dilate, to stent, or to operate?

Authors:  Pierre-François Plouin; Patrick Rossignol; Guillaume Bobrie
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

2.  Toward more rational management of ischemic nephropathy: the need for clinical evidence.

Authors:  K R Tuttle
Journal:  Am J Kidney Dis       Date:  2000-10       Impact factor: 8.860

3.  Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials.

Authors:  Natalie J Ives; Keith Wheatley; Rebecca L Stowe; Pieta Krijnen; Pierre-Francois Plouin; Brigit C van Jaarsveld; Richard Gray
Journal:  Nephrol Dial Transplant       Date:  2003-02       Impact factor: 5.992

4.  The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods.

Authors:  Timothy P Murphy; Christopher J Cooper; Lance D Dworkin; William L Henrich; John H Rundback; Alan H Matsumoto; Kenneth A Jamerson; Ralph B D'Agostino
Journal:  J Vasc Interv Radiol       Date:  2005-10       Impact factor: 3.464

Review 5.  Renovascular hypertension and ischemic nephropathy.

Authors:  Vesna D Garovic; Stephen C Textor
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

6.  Human blood pressure determination by sphygmomanometry.

Authors:  D Perloff; C Grim; J Flack; E D Frohlich; M Hill; M McDonald; B Z Morgenstern
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

7.  Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis.

Authors:  J Radermacher; A Chavan; J Bleck; A Vitzthum; B Stoess; M J Gebel; M Galanski; K M Koch; H Haller
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

8.  Effect of renal-artery stenting on progression of renovascular renal failure.

Authors:  P N Harden; M J MacLeod; R S Rodger; G M Baxter; J M Connell; A F Dominiczak; B J Junor; J D Briggs; J G Moss
Journal:  Lancet       Date:  1997-04-19       Impact factor: 79.321

9.  Renovascular disease in diabetes mellitus: treatment by percutaneous transluminal renal angioplasty.

Authors:  A Zuccalà; F Losinno; A Zucchelli; P C Zucchelli
Journal:  Nephrol Dial Transplant       Date:  1998       Impact factor: 5.992

10.  Advanced renovascular hypertension and renal insufficiency: trends in medical comorbidity and surgical approach from 1970 to 1993.

Authors:  J W Hallett; S C Textor; P B Kos; G Nicpon; T C Bower; K J Cherry; P Gloviczki; P C Pairolero
Journal:  J Vasc Surg       Date:  1995-05       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.